Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 6/20 | 0.57 |
| ▸ | AKR1C2 | P52895 | 6/20 | 0.57 |
| ▸ | ADH5 | P11766 | 1/20 | 0.49 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.46 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.46 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ESRRG | P62508 | 1/20 | 0.43 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.43 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.43 |
| ▸ | PLK4 | O00444 | 1/20 | 0.43 |
| ▸ | AURKA | O14965 | 1/20 | 0.43 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.43 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.43 |
| ▸ | CDK1 | P06493 | 1/20 | 0.43 |
| ▸ | PIM1 | P11309 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | FLT4 | P35916 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL402398 | 0.86 | ADH5 (0.58) | AKR1C3AKR1C2ADH5SRD5A2EPHX2 | |
| SCHEMBL505879 | 0.81 | AKR1C3 (0.56) | AKR1C3AKR1C2ADH5PLK4AURKA | |
| SCHEMBL23302210 | 0.81 | ADH5 (0.63) | AKR1C3AKR1C2ADH5SRD5A2EPHX2 | |
| SCHEMBL336261 | 0.81 | ADH5 (0.54) | AKR1C3AKR1C2ADH5SRD5A2P4HB | |
| Hydrochloric Acid SCHEMBL28670680 | 0.80 | ADH5 (0.61) | AKR1C3AKR1C2ADH5SRD5A2EPHX2 | |
| Hydrochloric Acid SCHEMBL7740677 | 0.79 | ADH5 (0.52) | AKR1C3AKR1C2ADH5SRD5A2P4HB | |
| Hydrochloric Acid SCHEMBL9229512 | 0.79 | ADH5 (0.52) | AKR1C3AKR1C2ADH5SRD5A2P4HB | |
| SCHEMBL31268441 | 0.79 | ADH5 (0.54) | AKR1C3AKR1C2ADH5SRD5A2 | |
| SCHEMBL4539558 | 0.79 | AKR1C3 (0.55) | AKR1C3AKR1C2ADH5PDE3BPDE3A | |
| SCHEMBL21271844 | 0.78 | AKR1C3 (0.53) | AKR1C3AKR1C2ADH5SRD5A2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8273776-B2 | Biphenyl oxadiazole derivatives as sphingosine-1-phosphate receptors modulators | ALLERGAN, INC (US) | 2012-09-25 | — | — | US | disclosed |
| US-20110257232-A1 | BIPHENYL OXADIAZOLE DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE RECEPTORS MODULATORS | ALLERGAN, INC. (US) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257232-A1 | BIPHENYL OXADIAZOLE DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE RECEPTORS MODULATORS | S1PR3, S1PR1, S1PR2 | AKR1C3 724/4885AKR1C2 1043/4885ADH5 2065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.